SCHEMBL5007909

SCHEMBL5007909

N[C@H]1CC[C@](N)(C(=O)O)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 8/20 0.54
CYP1A2 P05177 4/20 0.54
GRM2 Q14416 3/20 0.54
GRM3 Q14832 3/20 0.54
CYP2C19 P33261 3/20 0.54
ALOX15 P16050 3/20 0.54
TDP1 Q9NUW8 2/20 0.54
GRM8 O00222 2/20 0.54
GRM6 O15303 2/20 0.54
LMNA P02545 1/20 0.54
GRM5 P41594 1/20 0.54
MTOR P42345 1/20 0.54
GRM1 Q13255 1/20 0.54
PLCB1 Q9NQ66 1/20 0.54
TSHR P16473 1/20 0.54
NSD2 O96028 1/20 0.48
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5007910 1.00 GRM4 (0.54) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL5007908 1.00 GRM4 (0.54) GRM4CYP1A2GRM2GRM3CYP2C19
1-Aminocyclopropane Carboxylic Acid SCHEMBL28110484 0.92 NSD2 (0.56) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL10347256 0.84 ARG1 (0.45) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL18188079 0.80 GRM4 (0.39) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL544530 0.80 GRM4 (0.54) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL160783 0.80 GRM4 (0.54) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL912861 0.80 GRM4 (0.54) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL8535034 0.78 GRM4 (0.52) GRM4CYP1A2GRM2GRM3CYP2C19
SCHEMBL14372097 0.78 GRM4 (0.52) GRM4CYP1A2GRM2GRM3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432302-B2 Composition containing polyamine transport inhibitor and use thereof MEDIQUEST THERAPEUTICS, INC. (US) 2008-10-07 US disclosed
US-20050245615-A1 Composition containing polyamine transport inhibitor and use thereof MEDIQUEST THERAPEUTICS, INC. (US) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245615-A1 Composition containing polyamine transport inhibitor and use thereof SLC7A1, SRM, SLC16A1 GRM4 3939/4885CYP1A2 2431/4885GRM2 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.